Fed. Circ. Judge Considers Retrying Alere Drug-Test IP Fight
A Federal Circuit judge appeared to buy into Rembrandt Diagnostics' argument Monday that it should get a new trial because a district court misconstrued two key terms in a drug-testing patent...To view the full article, register now.
Already a subscriber? Click here to view full article